SpaceX Acquires AI Coding Tool Cursor and Parent Anysphere for $60B

Why It Matters

The unprecedented scale of the Cursor deal and overall M&A spend signals deep liquidity and aggressive growth strategies across tech and biotech, reshaping competitive dynamics and valuation benchmarks for venture‑backed firms.

Key Takeaways

• SpaceX's $60B purchase of Cursor sets all‑time startup acquisition record
• 2026 US startup M&A already exceeds $119.8B, on track to beat 2025
• Biotech makes half of deals, led by Eli Lilly's $7B Kelonia buy
• Capital One, Qualcomm, Salesforce each spend over $3B on non‑biotech acquisitions
• Biotech deals rely on milestone‑based payouts, adding valuation uncertainty

Pulse Analysis

The $60 billion Cursor acquisition by SpaceX not only shatters the previous $32 billion record set by Google’s purchase of Wiz, it also underscores a broader willingness among deep‑pocketed corporations to pay premium prices for strategic AI capabilities. Analysts view the deal as a bet on the next generation of developer tools that could accelerate SpaceX’s own software stack, while the sheer size of the transaction inflates the average deal value across the U.S. startup M&A landscape, pushing 2026 toward a historic peak.

Biotech activity has been a parallel driver of the record‑setting environment. Eli Lilly’s trio of deals—Kelonia Therapeutics at up to $7 billion, Orna Therapeutics at $2.4 billion and Ajax Therapeutics at $2.3 billion—illustrate how pharmaceutical giants are leveraging venture‑backed pipelines to replenish pipelines and diversify revenue streams. These agreements often hinge on milestone‑based earn‑outs tied to clinical outcomes, introducing valuation uncertainty but also aligning incentives for rapid product development.

Beyond biotech, financial services and semiconductor firms are also flexing their acquisition muscles. Capital One’s $5.15 billion purchase of Brex, Qualcomm’s $4 billion buy of Modular, and Salesforce’s multi‑billion investments in AI‑focused startups reflect a cross‑industry scramble for data‑rich, AI‑enabled platforms. As the second quarter closes, investors should monitor whether the momentum sustains, especially as companies balance large cash outlays against integration risk and the evolving regulatory landscape governing AI and health‑tech mergers.

Deal Summary

SpaceX completed a $60 billion acquisition of Cursor, an AI coding tool, and its parent Anysphere, marking the largest startup acquisition ever. The deal closed in June 2026 after SpaceX’s IPO, accounting for about half of US startup M&A spending this year.